Atralin® Gel
Indication
Atralin® Gel (tretinoin) Gel, 0.05% is a retinoid indicated for the topical treatment of acne vulgaris.
Product Description
Atralin® Gel is a topical retinoid indicated for the treatment of mild to moderate acne vulgaris, available through doctor's prescription only.
Introduced to the U.S market in January 2008, Atralin® Gel is a water based gel that offers the efficacy of tretinoin with low potential for irritation. Key ingredients such as hyaluronic acid, collagen and glycerin provide Atralin® with a more moisturizing formulation that helps offset the inherent drying effects of other topical retinoids. By helping patients stay compliant on their therapy, Atralin® Gel can lead to faster therapeutic outcomes. This makes Atralin® Gel an effective choice for dermatologists to prescribe for their sensitive skin teenage and adult acne patients.
Product Availability
- United States
Important Safety Information
The most common adverse reactions were mild to moderate irritation of the skin and occurred during the first few weeks of treatment with Atralin® Gel. To prevent aggravating the skin, protect it from sun, tanning lights, extreme wind or cold, and harsh skincare products. Use of sunscreen products of at least SPF 15 and protective clothing over treated areas is recommended when exposure cannot be avoided.